Toshio Asano
Toshio Asano
Member of the Board
Outside Director*
December 1952
- *Outside Director as defined in Article 2, Paragraph 15 of the Companies Act of Japan
- *Independent Director designated under the rules of the Tokyo Stock Exchange
Attendance at Board of Directors Meetings (FY2025):
14/14 (100%)
Career Summary
| April 1975 | Joined Asahi Chemical Industry Co., Ltd. (currently Asahi Kasei Corporation) |
|---|---|
| October 2003 | Executive Officer of Asahi Kasei Pharma Corporation |
| April 2010 | President, Presidential Executive Officer of Asahi Kasei Pharma Corporation |
| April 2011 | President, Presidential Executive Officer of Asahi Kasei Pharma Corporation; Executive Officer of Asahi Kasei Corporation |
| April 2014 | Presidential Executive Officer of Asahi Kasei Corporation |
| June 2014 | President & Representative Director, Presidential Executive Officer of Asahi Kasei Corporation |
| April 2016 | Director, Standing Counsellor of Asahi Kasei Corporation |
| June 2016 | Standing Counsellor of Asahi Kasei Corporation |
| June 2019 | Member of the Board of the Company (to present)* |
| June 2022 | Counsellor of Asahi Kasei Corporation |
| June 2024 | Special Advisor of Asahi Kasei Corporation (to present) |
- *Official English titles were revised effective July 2026.
- Outside Director of MEDIPAL HOLDINGS CORPORATION
- External Director of Daicel Corporation
- Special Advisor of Asahi Kasei Corporation
- Chairman, Japanese Foundation for Cancer Research
- President of Japan Bioindustry Association
- Outside Director of JCR Pharmaceuticals Co., Ltd.
Areas of Expertise and Expected Contributions
